GSK Investigational Site

East Setauket, New York 11733-9292

0 studies enrolling now · 5 studies all time

What they study most

Acellular Pertussis, Crohn's Disease, Diphtheria, Neoplasms, Breast, Ovarian Cancer, Ovarian Neoplasms, Tetanus

Studies at this site

• A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens — Completed
• Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed